ecancer
ecancer is a UK charity which provides accessible, high-quality educational content, free to the global oncology community. Our mission is to raise the standards of care for cancer patients across the world through education.
2023 EHA® Insights: "A Randomized Ph3 BMT-CTN 1506 (MORPHO) Trial of Gilteritinib as Post-Transplant Maintenance for FLT3-ITD AML"
By
ecancer
FEATURING
Mark Levis
By
ecancer
FEATURING
Mark Levis
Login to view comments.
Click here to Login
